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Abstract
Ticks are distributed worldwide and affect human and animal health by transmitting diverse infectious agents. Effective
vaccines against most tick-borne pathogens are not currently available. In this study, we characterized a tick histamine
release factor (tHRF) from Ixodes scapularis and addressed the vaccine potential of this antigen in the context of tick
engorgement and B. burgdorferi transmission. Results from western blotting and quantitative Reverse Transcription-PCR
showed that tHRF is secreted in tick saliva, and upregulated in Borrelia burgdorferi-infected ticks. Further, the expression of
tHRF was coincident with the rapid feeding phase of the tick, suggesting a role for tHRF in tick engorgement and
concomitantly, for efficient B. burgdorferi transmission. Silencing tHRF by RNA interference (RNAi) significantly impaired tick
feeding and decreased B. burgdorferi burden in mice. Interfering with tHRF by actively immunizing mice with recombinant
tHRF, or passively transferring tHRF antiserum, also markedly reduced the efficiency of tick feeding and B. burgdorferi
burden in mice. Recombinant tHRF was able to bind to host basophils and stimulate histamine release. Therefore, we
speculate that tHRF might function in vivo to modulate vascular permeability and increase blood flow to the tick bite-site,
facilitating tick engorgement. These findings suggest that blocking tHRF might offer a viable strategy to complement
ongoing efforts to develop vaccines to block tick feeding and transmission of tick-borne pathogens.
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Introduction
Ticks are distributed worldwide and affect human and animal
health by transmitting diverse infectious agents. Ticks are
considered to be second to mosquitoes as major vectors of human
diseases [1,2]. For example, Ixodes spp., transmit Borrelia burgdorferi
(the Lyme disease agent), Anaplasma phagocytophilum (the cause of
human granulocytic anaplasmosis), Babesia microti, and tick-borne
encephalitis virus (TBEV), among other pathogens [1,3].
Effective vaccines against most tick-borne pathogens are not
currently available and there is an urgent need for the control of
ticks and their associated pathogens [4]. Typical vaccines target
microbes directly, using extracts of the organism, or recombinant
antigens as the immunogen. For example, B. burgdorferi outer
surface protein A has been extensively studied and resulted in an
Federal Drug Administration-approved vaccine that was commer-
cially available from 1998 until 2002 [5,6]. Currently one vaccine
is approved and available for protection against a tick-borne
pathogen – TBEV, which is transmitted by I. ricinus in Northern
Europe and Asia [4].
The transmission of tick-borne pathogens can also theoretically
be prevented by interfering with the ability of ticks to feed on a
mammalian host [7]. A pilot study by Allen and Humphreys several
decades ago, suggested that vaccines based on tick gut antigens
successfully reduced Boophilus engorgement on cattle [8]. Recently,
immunization of guinea pigs with a tick salivary antigen, sialostatin
L2, diminished the capacity of Ixodes scapularis nymphs to feed [9].
While reducing the ability of tick feeding, tick-based vaccines may
have another equally important impact – to decrease the chance of
transmission of tick-borne pathogens [10]. Immunization of cattle
with Bm86 vaccines resulted in lower infestations as well as
decreased incidence of babesiosis and Anaplasma marginale infection
in some regions [1,7]. Repeated exposure of guinea pigs to ticks
causes acquired resistance of the animals to subsequent tick bites
[11,12], and this developmentof‘‘tick-immunity’’ candecrease tick-
transmitted B.burgdorferi infection[13]. B.burgdorferi need toreplicate
within the ticks during blood feeding and are transmitted to the host
after 36–48 h of tick attachment [2,14,15,16]. Thus, impairing I.
scapularis feeding could be another useful strategy to reduce B.
burgdorferi transmission.
Tick saliva contains molecules that are important for formation
and maintenance of the feeding cavity in the host dermis, as well as
the transmission of tick-borne pathogens [17,18]. These activities
include anti-hemostatic, anti-inflammatory and immunomodula-
tory effects, among others [17,19]. Histamine binding proteins are
well characterized and suggested to be important to neutralize the
inflammatory effect of histamine, which is secreted by host
immune cells at the tick feeding site and critical for Ixodes ticks to
successfully attach to the host [20,21]. Interestingly, Dermacentor
variabilis ticks also express a protein in their saliva, which shares
PLoS Pathogens | www.plospathogens.org 1 November 2010 | Volume 6 | Issue 11 | e1001205high homology with mammalian histamine release factor [22].
Given the deleterious effects of histamine on tick physiology, it is
very surprising that ticks encode a histamine release protein that
would presumably stimulate histamine secretion. The role of the
tick histamine release factor in vivo during tick feeding is not
understood and warrants detailed examination.
Tick feeding can be divided into a series of 9 stages [2]
beginning with host seeking, and culminating in engorgement on
the host followed by detachment and dropping off the host. A
feeding lesion is established about 24 h post attachment, and
during this early phase of feeding there is minimal blood intake.
Blood meal ingestion begins slowly around 48 h post tick
attachment followed by rapid feeding to repletion around 72 h–
96 h post tick attachment (late stage). While it is recognized that
the I. scapularis salivary gland proteome changes during these early
and late phases of feeding [13], a molecular understanding of these
events remains to be elucidated.
In this study, we have characterized a putative histamine release
factor from I. scapularis, the predominant vector of B. burgdorferi, the
agent of Lyme disease in North America. We invoke a pivotal role
for I. scapularis HRF during the rapid phase of tick feeding, and
address the vaccine potential of this antigen in the context of tick
engorgement and B. burgdorferi transmission.
Results
An I. scapularis histamine release factor (tHRF) is up-
regulated in B. burgdorferi-infected ticks
To identify tick proteins that may be utilized by B. burgdorferi to
facilitate transmission, 2-dimensional fluorescence difference gel
electrophoresis (DIGE) was performed using extracts from B.
burgdorferi-infected, and uninfected, I. scapularis salivary glands.
Seventeen differentially expressed proteins (5-fold or more expres-
sion levels in Borrelia-infected salivary glands) were selected for mass
spectrometric analysis, and 4 I. scapularis proteins were unambig-
uously identified with significant MASCOT scores (p,0.05) of 79
(Table S1). In this study, we characterize one of the most highly
induced proteins, named tHRF because it shares high homology
with a murine histamine release factor (57.1% similarity and 40.1%
identity at amino acid level). tHRF mRNA levels were induced
during I. scapularis engorgement, and significantly higher in B.
burgdorferi-infected, than in uninfected, ticks (p,0.01). Immunoblots
using tHRF antiserum further demonstrated a ,2.5 fold up-
regulation of tHRF in B. burgdorferi-infected ticks (Figure 1, A, C–D).
tHRF was present in tick saliva, as well as in the salivary glands and
midgut, indicating that it is a secreted protein (Figure 1E).
Silencing tHRF impairs tick feeding and Borrelia
transmission
To analyze the potential role of tHRF in tick feeding, and also
during B. burgdorferi transmission, tHRF-deficient I. scapularis nymphs
were generated by RNA interference (RNAi). Buffer-injected
(MOCK), SSRB (another tick gene- Single Sequence Receptor
Beta- found in our 2DIGE list, used as a control) or tHRF double-
stranded RNA (dsRNA)-injected B. burgdorferi-infected nymphs were
allowed to engorge on mice. The silencing of tHRF and SSRB were
confirmed by quantitative RT-PCR (Figure 2A). After 3 days, the
weighs of tHRF-deficient ticks were significantly lower than control
ticks (Figure 2B). Q-PCR revealed a decrease in spirochete levels in
tHRF-deficient ticks,as well as in the skin of micethat werefed upon
by tHRF-deficient ticks (Figure 2, C and D). At 3 weeks, when
spirochetes have disseminated to diverse organs, the B. burgdorferi
burden in the heart and joints was also lower in mice infected by
tHRF-deficient ticks, compared to that in mice infected with control
ticks (Figure 2, E and F).
To further show that tHRF directly influences tick feeding, an
RNAi study was performed with nymphs that were not infected
with B. burgdorferi. Consistent with the results using B. burgdorferi-
infected ticks, the tick weight was significantly decreased in tHRF-
dsRNA-treated uninfected I. scapularis after feeding (Figure 2G).
These data show that tHRF is critical for tick feeding, regardless of
whether B. burgdorferi are present within ticks.
tHRF antiserum prevents efficient tick feeding and
Borrelia transmission
To further examine the importance of tHRF during tick
feeding, and its influence on B. burgdorferi transmission, a passive
immunization study was performed in naive mice. Groups of 5
mice were administered 200 ml of tHRF antiserum, or control sera
(normal rabbit serum or Salp25D antiserum; Salp25D is a tick
salivary protein that does not influence tick feeding [23]). One day
later, 6 B. burgdorferi-infected ticks were placed on each mouse and
tick weights were assessed after 3 days of feeding. Ticks engorging
on tHRF antiserum-treated mice weighed significantly less than
ticks that fed on control mice (Figure 3A). The spirochete burden
in ticks was also substantially lower in I. scapularis that fed on tHRF
antiserum-immunized mice (Figure 3B). B. burgdorferi burden was
also markedly reduced in tHRF antiserum-immunized mice. The
spirochete load in murine skin at day 7 post-infection and in joints
and hearts at 3 weeks post-infection was markedly lower in tHRF
antiserum-immunized group compared to control serum immu-
nized group (Figure 3, C–E). About 20–27% of the tHRF
antiserum-immunized mice (N=15) were fully protected (based on
the absence of a detectable flaB signal in Q-PCR), while 100% of
the control animals were infected (N=30) (Figure 3, C–E).
Uninfected I. scapularis nymphs also fed less efficiently on tHRF
antiserum-treated mice (Figure 3F) as seen by decreased
engorgement weights compared to ticks fed on control antise-
rum-treated mice.
We then assessed the ability of the ticks to feed on mice actively
immunized with tHRF. Group of 5 mice were immunized with
recombinant tHRF, or adjuvant (control). Immunoblots confirmed
that mice generated antibodies against tHRF following active
immunization (Figure 4A). The tick weights were significantly
decreased when B. burgdorferi-infected, or uninfected, nymphs fed
Author Summary
Ticks are distributed worldwide and affect human and
animal health by transmitting diverse infectious agents.
Safe and effective vaccines against most tick-borne
pathogens are not currently available. Typical vaccines
target microbes directly, using extracts of the organism, or
recombinant antigens as the immunogen; the transmission
of tick-borne pathogens can also theoretically be prevent-
ed by interfering with the ability of ticks to feed on a
mammalian host. In this study, we have characterized a
putative histamine release factor (tHRF) from I. scapularis
ticks, the predominant vector of B. burgdorferi, the agent of
Lyme disease in North America. Our results suggested that
tHRF is presented in tick saliva and critical for tick feeding;
blocking tHRF markedly reduced the efficiency of tick
feeding, and reduced the B. burgdorferi burden in mice.
This finding provides novel insights into the molecular
mechanisms of tick feeding and provides a potential
vaccine target to block tick feeding and pathogen
transmission.
tHRF as a Tick Vaccine Candidate
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mice (Figure 4, B and C). The spirochete load was also markedly
reduced in ticks fed on tHRF-immunized mice (Figure 4D) and in
murine skin (at day 7 post-infection) (Figure 4E) and in joints and
hearts (at 3 weeks post-infection) in the tHRF-immunized group
compared to that in control mice (Figure 4, F–G). 20–33% of
tHRF immunized mice (N=15) were PCR negative, while 100%
of the mice in the control groups (N=15) were PCR positive for B.
burgdorferi flaB amplicon (Figure 4, E–G).
Our above experiments focused on 72 h post tick attachment- a
specific time point at which 30–40% of the ticks from the control
groups successfully complete engorgement and drop off the mice,
and the remaining ticks nearing engorgement. To address the role
of tHRF on 72–96h post tick attachment, all the ticks were allowed
to feed to repletion on tHRF antiserum immunized mice or
control mice. While, ticks in the control group fed to repletion and
detached around 72–84 h of attachment, ticks fed on tHRF-
immunized animals fed to repletion around 96 h after attachment.
Further, 10–20% of ticks from the tHRF group remained attached
to the mouse even after 96 h, (Figure S1A). The engorgement
weights of ticks fed on tHRF-antiserum immunized mice were also
significantly less than the engorgement weights of ticks fed on
control mice (Figure S1B), consistent with our data obtained from
72 h fed ticks (Figure 2–4).
tHRF binds to basophils and stimulates histamine release
Mammalian histamine release factor binds to basophils and
stimulates histamine release [24]. Since tHRF shares substantial
Figure 1. Tick histamine release factor (tHRF) was up-regulated in B. burgdorferi- infected ticks. (A) The expression of tHRF in B.
burgdorferi-infected or uninfected ticks during I. scapularis feeding. Results are expressed as the mean 6 the SEM (*p,0.05; **p,0.01). (B) tHRF-
antiserum recognizes recombinant tHRF generated in Escherichia coli (tHRF E.coli) or Drosophila S2 cells (tHRF DES). (C–D) The up-regulation of tHRF
protein in B. burgdorferi-infected ticks. (*p,0.05) (E) The detection of tHRF in adult tick saliva (Saliva), nymphal tick salivary glands (S.G.), midgut (M.G.)
and whole ticks (Tick).
doi:10.1371/journal.ppat.1001205.g001
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that tHRF might also adhere to host basophils and induce histamine
secretion. An in vitro binding assay was performed using a rat basophil
cellline andrecombinant tHRF (tHRF shares57%similaritywith rat
HRF at amino acid level, and rat HRF is 100% identical to mouse
HRF). Flow cytometry and confocal imaging showed that recombi-
Figure 2. Silencing tHRF impairs tick feeding and B. burgdorferi transmission. (A) tHRF and SSRB (another tick gene, as a control) were
silenced efficiently and specifically in nympal tick salivary gland by micro-injection of dsRNA. Results are expressed as the mean 6 the SEM. (B) The
weight of B. burgdorferi-infected ticks after feeding on naive mice. (C) The B. burgdorferi burden in whole ticks at 72 h post tick-engorgement.
Spirochete burden in (D) murine skin at day 7, (E) joints and (F) heart at day 21 post-infection. (G) The weight of uninfected ticks after feeding on
naive mice. Horizontal lines and bars represent the mean values 6 the SEM. * p,0.05 and ** p,0.01 when compared with MOCK controls. Results are
pooled from 3 independent experiments.
doi:10.1371/journal.ppat.1001205.g002
Figure 3. tHRF antiserum interferes with tick feeding and B. burgdorferi transmission. (A) Weights of B. burgdorferi-infected tick after
feeding on tHRF antiserum-immunized, or control, mice. (NRS: normal rabbit serum; rabbit anti-Salp25D antiserum, both used as controls) (B)
Spirochete burden in whole I. scapularis nymphs after feeding on tHRF antiserum-immunized, or control, mice. (C) B. burgdorferi burden in murine
skin at day 7 post-tick feeding. Spirochete burden in the (D) joints and (E) heart at day 21 post-tick feeding. (F) Weights of uninfected ticks after
feeding on tHRF antiserum-immunized, or control, mice. Horizontal lines and bars represent the mean values 6 the SEM. * p,0.05 and ** p,0.01,
when compared with the NRS controls. Results are a composite of independent experiments.
doi:10.1371/journal.ppat.1001205.g003
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the influence of tHRF on histamine release, basophils were incubated
with recombinant tHRF, or nymphal tick salivary gland extracts
(T.SGE). Recombinant tHRF and tick salivary gland extracts
stimulated histamine release from basophils (Figure 5C).
tHRF is required for tick rapid feeding
Ticks are sensitive to histamine during the early stage of blood
feeding, and express histamine binding proteins to counteract this
effect. However, tick sensitivity to histamine wanes after 3 days of
attachment to a host [20]. Quantitative RT-PCR analysis showed
preferential expressions of 3 histamine binding proteins in the
salivary glands of I. scapularis nymphs at 24–48 h post tick
attachment (Figure 6A–C). However, tHRF was preferentially
expressed at 48–72 h post tick attachment (Figure 6 D). Since
tHRF induces histamine release, histamine might play an under-
appreciated role in the late/rapid phase of tick feeding. To
confirm this, histamine or recombinant tHRF was injected into the
skin - at the I. scapularis bite site - 60 h after tick-attachment. The
tick weights at 72 h were significantly increased when I. scapularis
nymphs fed on mice given histamine or recombinant tHRF
compared to ticks fed on control mice (Figure 6, E and F). The B.
burgdorferi burden was also higher in ticks fed on tHRF-treated
mice compared to ticks that fed on control mice (Figure 6G).
Discussion
The incidence of tick-borne diseases has steadily increased over the
past few years, and effective vaccines against most tick-borne
pathogens are not currently available [4]. I. scapularis is the major
vector of Lyme disease in the USA [2,15]. Further, Is c a p u l a r i scan
serve as efficient vectors of A. phagocytophilum, B. microti, and Powassan
virus (a tick-borne encephalitis causing virus). The last decade has
seen an increased functional understanding of tick salivary proteins
and their critical interactions with the host and pathogen [17,18,25].
This information has also offered a new approach to develop effective
vaccines against ticks and the pathogens they transmit by
simultaneously targeting the pathogen and the tick [26].
The identification of tick proteins potentially involved in
pathogen transmission is an important step in the development
of effective tick vaccines [1,18]. The presence of B. burgdorferi
within ticks may alter the expression level of selected genes that
encode antigens in saliva [19,27]. One of best characterized genes
is salp15 [27]; our recent study suggests that immunization with
Salp15 could reduce the transmission of B. burgdorferi from infected
ticks to mice, although Salp15 antibodies did not influence the
ability of ticks to feed. The action is mainly due to the interaction
between Salp15 antibody, Salp15 and Borrelia [26].
We performed a 2DIGE analysis to identify additional tick
salivary proteins modulated by spirochetes. We found that tHRF
was up-regulated in Borrelia-infected tick salivary glands. HRF is an
evolutionally conserved multiple-function protein [28], also a
novel cytokine that provokes the release of histamine by both IgE-
dependent and IgE-independent mechanisms from mammalian
basophils and mast cells [29]. In addition to mammalian HRF,
HRF homologs have also been identified in Plasmodium falciparum
parasite [30], Dermacentor variabilis [22,31,32] and Dermanyssus
gallinae [33]. The latter study further indicated that antibodies
against HRF increased the mortality of the mites after engorge-
ment, suggesting its potential as a vaccine antigen [33].
Histamine, secreted by basophils in blood and mast cells in
tissues, plays a deleterious role during tick feeding. Histamine is a
mediator of the itch response and promotes the recruitment of
pro-inflammatory cells to the tick bite site – and these immune
response prevent tick attachment to the skin of the host [20,34].
However, the Ixodes tick encodes several histamine binding
proteins (HBPs) to counteract the effect of histamine [21,35]. The
elaboration of a histamine release factor in tick salivary glands
Figure 4. Tick feeding and B. burgdorferi transmission was significantly impaired in tHRF immunized mice. (A) tHRF probed with sera
from mice or rabbits actively immunized with tHRF. (B) Weights of B. burgdorferi uninfected or (C) infected tick after feeding on tHRF-immunized, or
control, mice. (D) Spirochete burden in whole I. scapularis after feeding on tHRF-immunized, or control, mice. (E) B. burgdorferi burden in murine skin
at day 7 post-tick feeding. Spirochete burden in the (F) joints and (G) heart at day 21 post-tick feeding. Horizontal lines and bars represent the mean
values 6 the SEM. * p,0.05 and ** p,0.01, when compared with the control group. Results are pooled from 3 independent experiments.
doi:10.1371/journal.ppat.1001205.g004
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detrimental to tick feeding. Mulenga et al. [22] suggested that ticks
might need either HBPs or HRF, depending on its feeding phase.
Tick feeding involves a complex series of 9 sequential stages [2].
Host seeking and engagement with the host precede actual tick
attachment and establishment of the feeding lesion. The early
phase of tick feeding that lasts about 24 h post attachment is
sensitive to histamine [20]. We observed increased expression of
Histamine Binding Proteins (HBP)i nI. scapularis nymphal salivary
glands during this early phase of tick feeding and might be critical
to counter the effect of histamine (Figure 6). Ticks imbibe very
little blood during this early phase of feeding. About 60–72h post
tick attachment, which includes the rapid feeding phase, tick
sensitivity to histamine significantly declines [20,34], and ticks fully
engorge. During this phase the expressions of HBPs appear to be
significantly decreased, and the expression of tHRF increases
(Figure 6). We speculate that this reciprocal expression of HBPs
and tHRF might help increase the local concentration of
histamine at the tick-feeding site during the rapid feeding phase.
Increased histamine concentration might modulate the vascular
permeability to enhance blood flow into the tick feeding site and
facilitate tick engorgement.
B. burgdorferi replicate after the tick begins to take a blood meal,
and transmission to the host begins about 36–48 h post tick
attachment, a time coincident with active spirochete replication
and migration to the salivary glands [14,36]. Temperature and
host blood are critical signals for B. burgdorferi replication and
dissemination from the midgut. Since the feeding ability of the
tHRF-deficient ticks was significantly impaired, the replication
and dissemination of Borrelia inside the ticks was also significantly
decreased (Figure 2C). Consequently, the spirochete transmission
from tick to mouse was also reduced (Figure 2D), and 20–30% of
the mice immunized with tHRF were fully protected from Borrelia
infection based on the absence of a detectable flaB signal in Q-
PCR (Figure 3 and 4). It is also conceivable that the vasodilatory
effect of histamine, might additionally contribute to the efficient
dissemination of Borrelia from the original tick-feeding site, where
they are deposited, to distal sites.
Insummary,forthefirsttime,wedemonstratethat theI.scapularis
salivary protein tHRF is critical for the tick engorgement, and
consequently also facilitates Borrelia transmission to the murine host.
We show that B. burgdorferi upregulates the expression of tHRF and
immunization with tHRF significantly impairs tick feeding, and
decreases B. burgdorferi burden in mice. Importantly, these
observations underscore the dynamic nature of the temporal
interactions between the vector, the host and the pathogen. While
vaccine targeting of tHRF alone might not be sufficient to thwart
tick feeding and spirochete transmission, blocking tHRF might offer
a viable strategy to complement ongoing efforts to develop vaccines
to block tick feeding and transmission of tick-borne pathogens.
Figure 5. tHRF binds to basophils and stimulates histamine release. (A) Flow cytometric analysis of recombinant tHRF binding to basophils,
– as defined by the shift in the FL1 (green) channel when compared to the controls. (B) Confocal imaging of recombinant tHRF binding to the surface
of basophils (tHRF+ Alexa 488 labeled tHRF Ab). and Negative control (PBS+Alexa 488 labeled tHRF Ab). Nuclei were counterstained with TOPRO3. (C)
Recombinant tHRF (generated from Drosophila (DES) or E. coli) and extract from nymphal tick salivary gland (T. SGE) stimulate histamine release from
basophils. Recombinant tHRF (DES) induces histamine release in a dose-dependent manner. Recombinant GST used as a negative control; Substance
C48/80, a calcium ionophore shown to induce histamine release in basophils [22] served as a positive control. Results are expressed as the mean 6
the SEM. Representative results from at least 3 independent experiments were shown.
doi:10.1371/journal.ppat.1001205.g005
tHRF as a Tick Vaccine Candidate
PLoS Pathogens | www.plospathogens.org 6 November 2010 | Volume 6 | Issue 11 | e1001205Materials and Methods
B. burgdorferi, ticks, and mice
An infectious and low passage isolate of B. burgdorferi N40 was
used to generate B. burgdorferi-infected ticks. Larval, nymphal, and
adult I. scapularis were maintained in our laboratory. Clean larvae
were fed either on naı ¨ve C3H mice to generate naı ¨ve nymphs or
on B. burgdorferi-infected C3H mice to generate infected nymphs.
Female C3H/HeJ (C3H) mice, 4 to 6 weeks of age, were obtained
from the Jackson Laboratory.
Ethics statement
Animals were housed and handled under the Guide for the
Care and Use of Laboratory Animals of the National Institutes of
Figure 6. tHRF is required for tick rapid feeding. Quantitative RT-PCR assessment of the expression pattern of: (A) tick histamine binding
protein 1 (HBP1), (B) HBP2, (C) HBP3 and (D) tick histamine release factor (tHRF). (E) Weights of ticks at 72 h post tick attachment on mice treated with
histamine (10mM) or PBS (control). (F) Weights of ticks at 72 h post tick attachment on mice treated with recombinant tHRF (10mg) or GST (control).
(G) B. burgdorferi burden in ticks fed on mice treated with recombinant tHRF (10mg) or GST (control). Horizontal lines and bars represent the mean
values 6 the SEM. * p,0.05 and ** p,0.01. Representative results from at least 3 independent experiments were shown.
doi:10.1371/journal.ppat.1001205.g006
tHRF as a Tick Vaccine Candidate
PLoS Pathogens | www.plospathogens.org 7 November 2010 | Volume 6 | Issue 11 | e1001205Health. The animal experimental protocol was approved by the
Yale University’s Institutional Animal Care & Use Committee
(Protocol Permit Number: 2008-07941). All animal infection
experiments were performed in a Bio-safety Level 2 animal facility,
according to the regulations of Yale University.
2D fluorescence differential gel electrophoresis (DIGE) of
nymphal salivary gland proteins
A quantitative analysis of the I. scapularis salivary gland
proteome was carried out by 2D fluorescence differential gel
electrophoresis (DIGE) at the W.M. Keck Facility at Yale
University. Salivary gland extracts from 200 clean and Borrelia-
infected I. scapularis nymphs fed for 66–72 h were suspended in a
cell lysis buffer (7M urea, 2M thiourea, 4% CHAPS, 25 mM Tris,
pH 8.6 at 4uC) and equal amounts of protein (50 mg) from Borrelia-
infected and clean salivary gland extracts were then differentially
labeled in vitro with Cy3 and Cy5 N-hydroxysuccinimidyl ester
dyes as described in the Ettan DIGE manual (GE Healthcare, NJ)
and electrophoresis and analysis performed essentially as described
earlier [13]. The gel was sequentially scanned using the Typhoon
9410 Imager (GE Healthcare, Piscataway, NJ) and images
exported into the DeCyder (GE Healthcare, NJ) software package
to assess differentially expressed protein spots. The protein spots
that were increased at least 5-fold in Borrelia-infected salivary
glands were excised for identification. The gel spots of interest
were robotically digested using trypsin prior to analysis on an
Applied Biosystems 4800 MALDI-Tof/Tof mass spectrometer.
The data was analyzed using the Applied Biosystems GPS
Explorer software with Mascot analysis against the NCBI nr
database, and a combined peptide mass fingerprint/MS/MS
search was done. Spots identified with significant MASCOT
scores (P,0.05) of 79 were tabulated.
RNAi
Fed-nymph salivary gland cDNA was prepared as described
[37] and used as template to amplify cDNA of tHRF (GenBank
accession no. DQ066335), and SSRB (Signal sequence receptor
beta, another tick gene used as a control) (GenBank accession
no. DQ066202). The primer sequences are indicated in Table S2
(P11, 12 for tHRF; P13, 14 for SSRB). The resultant amplicons
were purified and cloned into the SacII-XhoI sites of the L4440
double T7 Script II vector [37]. dsRNA complementary to the
DNA insert was synthesized by in vitro transcription using the
Megascript RNAi kit (Ambion, Austin, TX). The dsRNA was
purified and quantified spectroscopically. The microinjection of
dsRNA was performed as described previously [37]. Briefly, we
injected <4 nl of dsRNA (1610
9 molecules per nl) or buffer alone
(MOCK) into the ventral torso of the idiosoma of nymphal I.
scapularis. The ticks were allowed to rest for 4,6 hrs before feeding
on mice.
Quantitative PCR
DNA was extracted from mouse tissues and ticks using a
DNeasy tissue kit (QIAGEN, Valencia, CA) according to the
manufacturer’s protocol. The nymphal ticks (unfed or fed for 24,
48, and 72 h) were dissected under the microscope to get the tick
salivary gland and midgut. Total RNA was extracted using
RNeasy mini spin columns (QIAGEN). RNA was converted into
first-strand cDNA using random hexamers and Superscript III
reverse transcriptase (Invitrogen, Carlsbad, CA) according to the
manufacturer’s protocol.
All quantitative PCR (Q-PCR) assays were performed with an
iCycler (Bio-Rad Laboratories, Hercules, CA) using gene-specific
primers, and IQ SYBR green quantitative PCR system (Bio-Rad)
or a Taqman quantitative PCR system (Applied Biosystems, CA)
with a program consisting of an initial denaturing step of 3 min at
95uC and 45 amplification cycles consisting of 30 s at 95uC
followed by 1 min at 60uC. The gene-specific primers (and probes,
for Taqman Q-PCR) used for Q-PCR were indicated in Table S2.
Recombinant protein, antibody production and western
blot
The full open reading frame of tHRF was amplified from the tick
salivary cDNA library using gene specific primers P15, 16 (Table
S2). The PCR product was subcloned into the pGEX-6P2 vector
(Invitrogen, CA) and transfected into E.coli BL21/DE3 strain for
protein expression. The recombinant tHRF was purified by GST
sephorose 4B and the GST tag was removed by the precision
protease on column according to the manufacturer’s protocol.
To make recombinant protein using the Drosophila S2 cell
system, the full open reading frame of tHRF was subcloned into
pMT/BiP/V5-His A vector (Invitrogen) using primers P17, 18
(Table S2) and transfected into Drosophila S2 cells (Invitrogen,
CA) in combination with the hygromycin selection vector
pCOHYGRO for stable transfection. The stable transformants
were selected using 300 mg/ml hygromycin-B for 3–4 weeks. The
recombinant tHRF with 6-His tag were induced and purified with
Talon affinity column as described previously [38].
To generate polyclonal antisera, tHRF (without the GST tag)
produced in E. coli was emulsified in complete Freund’s adjuvant
and injected into groups of 2–3 rabbits (100 mg/animal). The
animals were boosted twice at 3-week intervals with the same dose
of antigen in incomplete Freund’s adjuvant, and the sera were
collected 2 week after the second boost.
A western blot was performed to analyze the protein expression
of tHRF in adult tick saliva, nymphal salivary gland extract,
midgut extract and whole nymphs. The tick saliva and tissue
extract were prepared as described [22]. Protein preparations were
separated on a 4–15% gradient poly-acrylaminde gel and
transferred on to a PVDF membrane. The membranes were
probed with polyclonal anti-tHRF antibody followed by HRP-
conjugated anti-Rabbit IgG and detected with enhanced luminol-
based detection (ECL) kit (GE bioscience).
Passive and active immunization
Groups of 5 mice were passively immunized with 200 mlo f
normal rabbit serum, anti-Salp25D antiserum (as controls) or anti-
tHRF antiserum, respectively (Salp25D is a tick salivary protein
that does not influence tick feeding [23]). 24 h after immunization,
6 B. burgdorferi-infected nymphal ticks or 10 non-infected nymphs
were placed on each mouse. After 72h, the ticks were collected and
weighed to analyze the feeding efficiency. For the B. burgdorferi-
infected tick experiment, the Borrelia burden in ticks as well as in
the localized skin specimen at 7 post tick repletion and in the
murine heart and joints at 3 weeks post-infection were determined
by measuring flaB copies using quantitative PCR.
To address the role of tHRF on 72–96 h post tick attachment,
all the ticks were allowed to feed to repletion on tHRF antiserum
immunized mice or control mice (normal rabbit serum immu-
nized). After 60 h post tick attachment, the mice were examined
every 12 h and the number of tick detached from the mice were
recorded. The weights of ticks after repletion were measured as
described above.
In the active immunization study, groups of 5 mice were
immunized by subcutaneously injecting 10 mg of purified recom-
binant tHRF suspended in complete Freund’s adjuvant, or
adjuvant alone (mock control). Mice were boosted with 5 mgo f
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weeks. Before tick challenge, mice were bled and the anti-tHRF
antibody titer was analyzed by western blot. The tick challenge
and pathogen burden analysis were performed using the same
methods described above.
Binding and histamine release assay
To test whether tHRF binds to mammalian basophils, an in vitro
binding assay was performed as described previously [24]. Briefly,
a rat basophilic leukemia cell line RBL-2H3 was purchased from
American type culture collection (ATCC, Manassas, VA). Cells
were cultured to confluence in a 6-well plate and then incubated
with recombinant tHRF (generated from E. coli) or GST in 1%
FCS or buffer alone at 4uC for 2hrs. After 3 washes with PBST
(PBS+ 0.1% Tween 20), the cells were incubated with purified
Alexa 488 labeled anti-tHRF IgG or Alexa 488-anti-GST IgG in
1% FCS plus 1% rat isotype IgG buffer. The IgG labeling was
performed using the Alex488 easy labeling kit (Invitrogen, CA)
according to manufacture’s direction. After 3 washes with PBST,
the cells were fixed with 4% PFA and permeablized with 1%
Triton X-100, and the nuclei were stained with TOPRO3. The
cells were then analyzed by microscopy and Flow Cytometry.
To investigate whether tHRF can induce histamine secretion
from basophils, a histamine release assay was performed using the
method described [22]. The possible endotoxins from all test
protein preparations were eliminated by passing the protein
preparations through endotoxin-free columns (PIERCE, Rock-
ford, IL). Varying concentrations of 5, 0.5 and 0.1 mgm l
21 of
endotoxin-free HRF (DES) or GST (as negative control) were
added to confluent RBL-2H3 cells (in 2 ml media) and incubated
at 37uC for 30 min. To determine whether, native tHRF in tick
tissue extracts could also induce histamine release, 1.0 mgm l
21
nymphal tick salivary gland extracts were assayed for histamine
release. Substance C48/80 (Sigma, St Louis, MO), a calcium
ionophore was used at 0.5 mgm l
21 for positive control. A
histamine ELISA kit purchased from Research diagnostic Inc.
(Flanders, NJ) was used to determine histamine concentrations in
culture supernatants.
Effect of histamine or tHRF on tick rapid feeding
To investigate the role of histamine and tHRF on late stage of
tick feeding, B. burgdorferi infected nymphal ticks were fed on naı ¨ve
mice for 60h. Then 10mM of histamine or 10 mg of recombinant
tHRF were injected into the mouse skin at the tick bite site (usually
around the ear). Control mice were given the same amount of PBS
or recombinant GST. At 72h post-tick attachment, the tick
weights were measured and B. burgdorferi burden in ticks were
analyzed by Q-PCR.
Statistics
Results are expressed as the mean 6 the SEM. The significance
of the difference between the mean values of the groups was
evaluated by Student’s t test with StatView software (SAS
Institute).
Gene accession numbers
The GenBank accession numbers for the genes related with this
study: tHRF/DQ066335; SSRB/DQ066202; Salp25D/AF209-
911; HBP1/DQ066014; HBP2/DQ066128; HBP3/DQ066002.
Supporting Information
Figure S1 tHRF antiserum significantly delays tick feeding. A)
Assessment of percentage of replete ticks at different time points
post tick attachment on immunized mice. (NRS: normal rabbit
serum). Results are expressed as the mean + the SEM. B) The
weights of replete ticks. Horizontal lines and bars represent the
mean values 6 the SEM. * p,0.05. Representative results from at
least 3 independent experiments were shown.
Found at: doi:10.1371/journal.ppat.1001205.s001 (0.57 MB TIF)
Table S1 2D Fluorescence Differential Gel Electrophoresis
(DIGE) analysis and identification of proteins with increased
expression in Borrelia burgdorferi-infected nymphal salivary glands by
Matrix-Assisted Laser Desorption/Ionization.
Found at: doi:10.1371/journal.ppat.1001205.s002 (0.03 MB
DOC)
Table S2 Oligonucleotide primers and probes.
Found at: doi:10.1371/journal.ppat.1001205.s003 (0.05 MB
DOC)
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